Ann: Annual Results Webinar, page-4

Highly recommend that EVERYONE submits this question in advance, as well as other questions in relation to other important catalysts that are needed for the market to properly value this. Questions inquiring about progress with Vitiligo and whether it is still on schedule (recruitment status, dates of readouts etc), the M lines and progress with that (such as whether they have a product ready for launch, the name of the product, timelines etc) and other similar things. Doesn't matter whether the questions get answered, it will show them that this is what investors need if there is overwhelming demand for information related to these items.

I am hopeful that the Annual Report and AGM will both be highly informative, and the next few months will see an aggressive buy back employed, but lets put the pressure on them.